CompletedPhase 2NCT00618072

EMPOWIR:Enhance the Metabolic Profile of Women With Insulin Resistance

Studying NON RARE IN EUROPE: Metabolic syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
New York Medical College
Principal Investigator
Harriette R Mogul, MD MPH
New York Medical College
Intervention
metformin and rosiglitazone(drug)
Enrollment
46 enrolled
Eligibility
35-55 years · FEMALE
Timeline
20082011

Study locations (1)

Collaborators

Albert Einstein College of Medicine · University of Tennessee

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00618072 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Metabolic syndrome

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Metabolic syndrome

← Back to all trials